[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556115":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":10,"centralContacts":28,"locations":38,"responsibleParty":57,"collaborators":10,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":65,"acronym":10,"eligibilityCriteria":66,"healthyVolunteers":63,"sex":67,"minAge":68,"maxAge":69,"enrollmentInfo":70,"targetDuration":10,"studyType":73,"phases":10,"briefSummary":74,"conditions":75,"keywords":10,"overallStatus":41,"whyStopped":10,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":86},{"fullName":5,"class":6},"Fayoum University","OTHER",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients has ischemic heart failure",null,"30 patients will take statin.",[13],"Drug: Statin and SGLT2i",{"label":15,"type":10,"description":16,"interventionNames":17},"Patients has ischemic heart","30 patients will take both of statin and SGLT2i.",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Patients has heart disease","30 patients will take SGLT2i.",[13],[23],{"type":24,"name":25,"description":26,"armGroupLabels":27,"otherNames":10},"DRUG","Statin and SGLT2i","Statin as atrovastatin SGLT2i as dapagliflozin",[19,15,9],[29,34],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Raghda Roshdy","CONTACT","01010647666","Raghda.hussien@pharm.bsu.edu.eg",{"name":35,"role":31,"phone":36,"phoneExt":10,"email":37},"Marwa Kamal","01067789982","mka05@fayoum.edu.eg",[39],{"facility":40,"status":41,"city":42,"state":43,"zip":10,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Asmaa mohamed abdelkader","RECRUITING","Al Fayyum","Faiyum Governorate","Egypt","EG",{"type":47,"coordinates":48},"Point",[49,50],30.8418,29.30995,{"lat":50,"lon":49},[53,55],{"name":54,"role":31,"phone":32,"phoneExt":10,"email":33},"Raghda Roshdy, Assisstant professor",{"name":56,"role":31,"phone":36,"phoneExt":10,"email":37},"Marwa Kamal, Assisstant professor",{"type":58,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Asmaa Mohamed Abdelkader","\"The Effect of The combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart disease\"","100556115","the-effect-of-the-combination-therapy-of-statin-and-sglt2i-in-the-treatment-of-ischemic-heart-disease-100556115",false,"NCT06520891","\"The Effect of The Combination Therapy of Statin and SGLT2i in The Treatment of Ischemic Heart Disease\"","Inclusion Criteria:\n\n* we include patients established ischemic heart failure seen by a primary care provider to diagnose ischemic heart disease,\n* They assessed the use of statin with SGLT2i.\n\nExclusion Criteria:\n\n* We exclude patients with\n\n  1. liver dysfunction.\n  2. renal dysfunction.\n  3. fungal infection.\n  4. coagulation disorder.\n  5. Pts using drugs that interact with SGLT2i.\n  6. patients that will refuse to be enrolled in the Study or refuse to write informed consent.","ALL","50 Years","80 Years",{"count":71,"type":72},90,"ESTIMATED","OBSERVATIONAL","correlate the serum level of statin and SGLT2i when given as polytherapy with HPLC in ischemic heart failure patients and their laboratory tests (cholesterol, LDL, HDL and TG...)",[76],"2 Drugs Are Statin and SGLT2i","2025-09-10",{"date":79,"type":80},"2025-09-11","ACTUAL",{"date":82,"type":80},"2024-06-01",{"date":84,"type":72},"2025-12-30",{"name":5,"class":6},1]